ImaCor Revenue and Competitors
Estimated Revenue & Valuation
- ImaCor's estimated annual revenue is currently $5M per year.
- ImaCor's estimated revenue per employee is $251,000
Employee Data
- ImaCor has 20 Employees.
- ImaCor grew their employee count by -5% last year.
ImaCor's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Chief Medical Officer | Reveal Email/Phone |
2 | Founder | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Regional Sales Manager | Reveal Email/Phone |
5 | Quality Engineer | Reveal Email/Phone |
ImaCor Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $160M | 800 | 4% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is ImaCor?
ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the EVO ultrasound systems and the miniaturized, disposable ClariTEE® probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time. Founded in 2004 by two dedicated cardiologists, Scott Roth, M.D. and Steven Evans, M.D., and world-renowned scientist Harold Hastings, Ph.D., ImaCor's vision is that ultrasound-guided hemodynamic management will become the gold standard in advanced hemodynamic management for critical care globally, significantly impacting the quality and economics of patient care. ImaCor's EVO ultrasound systems and ClariTEE® probe have been used successfully to provide effective hTEE guidance for thousands of patients worldwide.
keywords:N/AN/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 20 | -5% | N/A |
#2 | $3.1M | 20 | 0% | N/A |
#3 | $3.5M | 21 | 0% | $15M |
#4 | N/A | 22 | -4% | N/A |
#5 | $4.2M | 22 | -15% | N/A |